SOD has been used to describe a variety of clinical conditions in patients with bilateral optic nerve hypoplasia and a spectrum of midline brain defects with or without endocrinologic abnormalities (Table 1). This evidence concerns the gene SOD1 and Autosomal dominant optic atrophy, classic type.